Best Ophthalmology Companies in Switzerland
The 37 best Ophthalmology companies in Switzerland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Sanoptis.
- Growth Foreseen for Ophthalmology Sector
Ranked: Best Ophthalmology companies in Switzerland
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Web popularity | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Sanoptis Network of eye clinics and practices offering ophthalmological services. | $270M | 17 mo ago | 500 | Volker Wendel CEO | WordPressMySQLPHP+20 | Top 10M | — | — |
| 2 | RhyGaze Developer of gene therapies to restore vision | $97M | 20 mo ago | — | Charles Gubser Co-Founder | PHPGSAPApache HTTP Server+15 | Top 50M | — | — |
| 3 | Oculis Developer of therapeutics for the treatment of ophthalmic conditions | $93M | 29 mo ago | 2 | Einar Stefansson Co-Founder | WordPressMySQLPHP+21 | Top 10M | 53 patents Cyclodextrin-based formulations for ophthalmic drug delivery and stability. | — |
| 4 | ESBATech Developer of antibody-based therapeutics for ophthalmic diseases | $63M | 217 mo ago | — | Dominik Escher CEO | — | — | 75 patents Engineered stable soluble antibodies and scFv formats for TNF‑alpha therapeutic inhibition | — |
| 5 | Allotex Corneal Allografts for the treatment of presbyopia, hyperopia, myopia, and astigmatism | $47M | 33 mo ago | — | Michael Mrochen Co-Founder | WordPressMySQLPHP+13 | Top 50M | — | — |
| 6 | Sensimed Provider of a contact lens-based glaucoma monitoring platform | $42M | 158 mo ago | — | — | WordPressMySQLPHP+16 | Top 50M | 103 patents Continuous intraocular pressure and ocular biomechanical property monitoring devices | — |
| 7 | Xigen Developing cell-penetrating peptide therapeutics to treat eye diseases | $41M | 202 mo ago | 6 | Geraldine Dury CEO & Director | — | — | 187 patents Patents concentrated in chemistry & materials | — |
| 8 | Ziemer Ophthalmology Portfolio of devices for refractive and corneal surgery | $17M | — | 220 | — | PlyrCloudflarecore-js+14 | Top 5M | — | — |
| 9 | Rheon Medical A non-invasively adjustable glaucoma drainage device for treating glaucoma | $6M | 69 mo ago | 7 | — | WordPressMySQLPHP+20 | Top 50M | — | — |
| 10 | machineMD Developer of a device for the diagnosis of brain disease | $5M | 17 mo ago | 16 | — | HubSpot CMS HubSplideFancyBox+12 | Top 50M | 9 patents Patents concentrated in health & consumer products | — |
| 11 | EarlySight Provider of retinal imaging solutions for retinal disorders | $3M | 12 mo ago | 11 | Francine Behar-Cohen Co-Founder | WordPressMySQLPHP+20 | Top 50M | 6 patents Non‑invasive transscleral optical imaging and retinal image acquisition for ocular disease diagnosis | — |
| 12 | Infinite Vision Optics Adjustable intraocular lenses for cataract patients | $3M | 134 mo ago | 7 | Carsten Laue CEO | — | — | — | — |
| 13 | MIKAJAKI Developer of eye health diagnostics products | $2M | 75 mo ago | 9 | Yann Voillot CEO | — | — | 9 patents Automated ocular ultrasound imaging systems for eye diagnostics | — |
| 14 | Inflamalps Swiss biopharmaceutical company developing topical treatments for inflammation-mediated diseases in… | $2M | 133 mo ago | 140 | Philippe Meuwly Co-founder & Board Member | — | — | 6 patents Botanical aqueous extracts from Aster species for therapeutic and cosmetic formulations. | — |
| 15 | Kejako Researches and develops medical devices for the ophthalmic surgery sector | $807K | 101 mo ago | 3 | David ENFRUN Co-Founder & CEO | — | — | 20 patents Intraocular accommodative lenses and iris prosthetic implants for vision correction | — |
Top 12 Ophthalmology companies in Switzerland
#1
Acquired · Zug, Canton of Zug · founded 2018 · 500 employees$269.9Mraised▾
Network of eye clinics and practices offering ophthalmological services. It provides a platform for modern eye clinics and practices. The company facilitates collaborations, investments, and training for improved patient care. It fosters knowledge sharing among medical professionals. The company supports recruitment and development of medical staff. It advises clinics and practices on optimizing operations, personnel, finance, and marketing. The company invests in equipment and facilities to ensure treatment in a comfortable environment.
- Mar 2025PE$269.9M
#2
Series A · Basel, Basel City · founded 2024$97.2Mraised▾
Developer of gene therapies to restore vision. It offers gene therapy technology that delivers a light-sensor gene specifically to cone cells to improve vision in patients suffering from retinal diseases causing blindness
- Jan 2025Series A$86M
- Jul 2024Seed$11.2M
#3
Seed · Lausanne, Vaud · founded 2016 · 11 employees$2.7Mraised▾
Provider of retinal imaging solutions for retinal disorders. By using the technology doctors can understand and visualize the origins of many diseases such as age-related macular degeneration. It allows the ophthalmologist to measure the cell density or size of the retina. It helps ophthalmologists to see the micro-vasculature structure and the small capillaries in retinal disorder.
- Sep 2025Seed$3.9M
- Oct 2023Seed$111.3K
- May 2021Seed$2.6M
- Feb 2020Conventional Debt$102.9K
#4
Seed · Bern, Canton of Bern · founded 2019 · 16 employees$4.8Mraised▾
Developer of a device for the diagnosis of brain disease. It offers NeurOphthalmoscope a diagnostic device for an automated, objective, and quantifiable analysis of brain functions related to the visual system.
- Mar 2025Seed—
- Sep 2022Seed$3.3M
- Dec 2021Seed$1.5M
#5
Public · Pully, Vaud · founded 2003 · 2 employees$93.2Mraised▾
Developer of therapeutics for the treatment of ophthalmic conditions. The company's product line include OCS-01 is a non-invasive topical formulation based on solubilizing nanoparticle technology. It is used for the treatment of diabetic macular edema, post-surgery cataract inflammation, and dry eye.
- Apr 2024Post IPO—
- May 2021Series C$57M
- Jan 2019Series B$15.7M
- Jan 2018Series B$20.5M
#6
Series B · Zurich, Zurich · founded 2016$46.7Mraised▾
Allotex is developing therapeutic solutions for the treatment of presbyopia, hyperopia, myopia, and astigmatism. The therapy is based on tissue addition technology that uses precisely-shaped human corneal allografts to create contact lens or lens insert. The corneal allografts can be placed on top of or just under Bowman’s (no need to place them deep in the cornea). It can be made in any shape, diameter, and thickness.
- Dec 2023Series B—
- Jul 2023Series B$30M
- Feb 2018Series B$16.7M
#7
Acquired · Lausanne, Vaud · founded 2003$41.8Mraised▾
Provider of a contact lens-based glaucoma monitoring platform. The company has developed a non-invasive soft contact lens-based solution for glaucoma management. It provides an automated recording of continuous ocular dimensional change over a day's duration. The product is CE and FDA approved.
- Jul 2013Series C$8.3M
- Nov 2012Series C$18M
- May 2010Series B$8.6M
- Dec 2007Series A$6.9M
#8
Acquired · Zurich, Zurich · founded 1998$63Mraised▾
Developer of antibody-based therapeutics for ophthalmic diseases
#9
Deadpooled · Epalinges, Vaud · founded 2002 · 6 employees$40.8Mraised▾
Xigen is developing therapeutic peptides for a broad range of diseases, with a focus on inflammation. Its technology platform, Xigen ICPT enables the design and synthesis of metabolically stable cell-penetrating peptides using proprietary carrier motifs to selectively deliver them to intracellular targets. The company's product pipeline includes - XG-102 targeting ocular inflammatory disorders (Ph III - cataract and hearing loss, Ph II - complex ocular surgery, Ph I - uveitis) and Alzheimer's disease, interstitial cystitis, nephrology (all preclinical); and XG-104 targeting dry eye.
- Nov 2009Series B$19.7M
- Mar 2009Grant (prize money)$722.4K
- Sep 2005Series A$21.1M
#10
Series B · Basel, Basel Stadt · founded 2005 · 220 employees$17.4Mraised▾
Ziemer Ophthalmic Systems develops and commercializes a range of devices for ophthalmic surgery (refractive, cataract and glaucoma) and ocular diagnostics (glaucoma and refractive/cornea). Its products include the Amadeus II Advanced 3-in-1 Microkeratome which is an alternative to femtosecond laser technology for many types of refractive and corneal surgery such as LASIK, epi-LASIK as well as anterior and posterior Lamellar Keratoplasty. Pascal dynamic contour tonometer based on DCT technology and includes a Disposable contact lens sensor, an Antenna for signal energy transfer, and a Data logger for data storing and power supplies; The Femto LDV range of femtosecond lasers for reftractive correction; Galilei for computerized tomography and topography which is useful in IoL selection, Surgical planning, Corneal implant planning , and Keratoconus screening.
- Series B$17.4M
#11
Series C · Lausanne, Vaud · founded 2010 · 7 employees$6.3Mraised▾
Rheon Medical is developing, eyeWatch device, a non-invasively adjustable glaucoma drainage device for treating glaucoma. It compresses the drainage tube by means of a rotatable magnetic disk, the fluidic resistance can be adjusted to maintain intraocular pressure within the optimal clinical-targeted range. The adjustment is performed non-invasively using an external control unit. It comes along with the eyeWatch Pen which allows the measurement and adjustment the eyeWatch's functional position. It has received CE Mark approval for use in Europe but has not received FDA approval as of March 2017.
- Dec 2020Series C$6.3M
- Oct 2016Seed—
#12
Seed · Plan les Ouates, Geneva · founded 2018 · 9 employees$2.5Mraised▾
Developer of a fully atomized ocular diagnostics platform designed to revolutionize eye health diagnostics. The company's platform uses digital technologies, robotics, artificial intelligence and data to provide superior reporting capabilities, enabling patients to receive quick access to the exact treatment they need and eye professionals to focus on their specialty and field of expertise.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Ophthalmology coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Medical Devices is moving in Switzerland
A read on the academic research around Medical Devices — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 97 Switzerland-affiliated papers.
- ETH Zurich12
- École Polytechnique Fédérale de Lausanne12
- University of Basel7
- Intuitive Surgical6
- University of Geneva6
- Robot2→6
- Surgical robot1→4
- Robotics2→6
- Health care1→8
- Product (mathematics)1→6
Where medical devices is researched across Switzerland
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.